These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37957926)

  • 21. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T; Kroger H; Pikalov A; Loebel A
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
    Singh V; Bowden CL; Mintz J
    Int Clin Psychopharmacol; 2013 Mar; 28(2):91-5. PubMed ID: 23238761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous valproate in the treatment of acute manic episode in bipolar disorder: A review.
    Fontana E; Mandolini GM; Delvecchio G; Bressi C; Soares JC; Brambilla P
    J Affect Disord; 2020 Jan; 260():738-743. PubMed ID: 31581039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania.
    Yatham LN; Binder C; Kusumakar V; Riccardelli R
    Int Clin Psychopharmacol; 2004 Mar; 19(2):103-9. PubMed ID: 15076019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating response to mood stabilizers in patients with mixed depression: A study of agreement between three different mania rating scales and a depression rating scale.
    Shansis FM; Reche M; Capp E
    J Affect Disord; 2016 Jun; 197():1-7. PubMed ID: 26950019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder.
    Marangell LB; Suppes T; Zboyan HA; Prashad SJ; Fischer G; Snow D; Sureddi S; Allen JC
    J Clin Psychiatry; 2008 Feb; 69(2):183-9. PubMed ID: 18211128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
    Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH; Kalali AH; Ketter TA;
    J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
    Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
    Sharpley AL; Williams C; Holder AA; Godlewska BR; Singh N; Shanyinde M; MacDonald O; Cowen PJ
    Psychopharmacology (Berl); 2020 Dec; 237(12):3773-3782. PubMed ID: 32909076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
    Potkin SG; Keck PE; Segal S; Ice K; English P
    J Clin Psychopharmacol; 2005 Aug; 25(4):301-10. PubMed ID: 16012271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS
    J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Open randomized comparative twelve-week study of lithium and valproate in manic episode].
    Mosolov SN; Kostiukova EG; Kapiletti SG; Belen'kaia DV; Shafarenko AA; Fedotov DD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):47-52. PubMed ID: 20032954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
    Ketter TA; Kalali AH; Weisler RH;
    J Clin Psychiatry; 2004 May; 65(5):668-73. PubMed ID: 15163253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.